Patents by Inventor Kaveri URKALAN

Kaveri URKALAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11286268
    Abstract: The present invention provides synthesis, pharmaceutically acceptable formulations and uses of compounds in accordance with Formula I, or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof. For Formula I compounds X1, X2, X3, X4, X5, X6, Q, L1, L2, Y, R1, R2, R3, R4, R5, R6, R7, R8 and rings A, B and C are as defined in the specification. The inventive Formula I compounds are inhibitors of eIF4e and find utility in any number of therapeutic applications, including but not limited to treatment of inflammation and various cancers.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: March 29, 2022
    Assignee: eFFECTOR Therapeutics, Inc.
    Inventors: Samuel Sperry, Alan X. Xiang, Justin T. Ernst, Siegfried H. Reich, Paul A. Sprengeler, Mike Shaghafi, Theo Michels, Christian Nilewski, Chinh Viet Tran, Garrick Kenneth Packard, Alan Grubbs, Kaveri Urkalan, Takasuke Mukaiyama
  • Patent number: 9981956
    Abstract: Described herein are compounds and compositions for the treatment of a fibrotic disease.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: May 29, 2018
    Assignees: The Scripps Research Institute, The California Institute for Biomedical Research
    Inventors: Luke Lairson, Michael Bollong, Peter G. Schultz, Arnab K. Chatterjee, Baiyuan Yang, Puneet Kumar, Kaveri Urkalan
  • Publication number: 20170217943
    Abstract: Described herein are compounds and compositions for the treatment of a fibrotic disease.
    Type: Application
    Filed: April 14, 2017
    Publication date: August 3, 2017
    Inventors: Luke LAIRSON, Michael BOLLONG, Peter G. SCHULTZ, Arnab K. CHATTERJEE, Baiyuan YANG, Puneet KUMAR, Kaveri URKALAN
  • Patent number: 9663499
    Abstract: Described herein are compounds and compositions for the treatment of a fibrotic disease.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: May 30, 2017
    Assignees: The California Institute for Biomedical Research, The Scripps Research Institute
    Inventors: Luke Lairson, Michael Bollong, Peter G. Schultz, Arnab K. Chatterjee, Baiyuan Yang, Puneet Kumar, Kaveri Urkalan
  • Publication number: 20160130258
    Abstract: Described herein are compounds and compositions for the treatment of a fibrotic disease.
    Type: Application
    Filed: June 5, 2014
    Publication date: May 12, 2016
    Inventors: Luke LAIRSON, Michael BOLLONG, Peter G. SCHULTZ, Arnab K. CHATTERJEE, Baiyuan YANG, Puneet KUMAR, Kaveri URKALAN